TY - JOUR
T1 - Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson's Disease
AU - Sharma, Yogita
AU - Shobha, K.
AU - Sundeep, Mata
AU - Pinnelli, Venkata Bharatkumar
AU - Parveen, Shagufta
AU - Dhanushkodi, Anandh
N1 - Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
PY - 2021/3/11
Y1 - 2021/3/11
N2 - Parkinson's Disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Though significant insights into the molecular-biochemical-cellular-behavioral basis of PD have been understood, there is no appreciable treatment available till date. Current therapies provide symptomatic relief without any influence on the progression of the disease. Stem cell therapy has been vigorously explored to treat PD. In this comprehensive review, we analyze various stem cell candidates for treating PD and discuss the possible mechanisms. We advocate the advantage of using neural crest originated Dental Pulp Stem Cells (DPSC) due to their predisposition towards neural differentiation and their potential to regenerate neurons far better than commonly used bone marrow derived mesenchymal stem cells (BM-MSCs). Eventually, we highlight the current challenges in the field and the strategies, which may be used for overcoming the impediments.
AB - Parkinson's Disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Though significant insights into the molecular-biochemical-cellular-behavioral basis of PD have been understood, there is no appreciable treatment available till date. Current therapies provide symptomatic relief without any influence on the progression of the disease. Stem cell therapy has been vigorously explored to treat PD. In this comprehensive review, we analyze various stem cell candidates for treating PD and discuss the possible mechanisms. We advocate the advantage of using neural crest originated Dental Pulp Stem Cells (DPSC) due to their predisposition towards neural differentiation and their potential to regenerate neurons far better than commonly used bone marrow derived mesenchymal stem cells (BM-MSCs). Eventually, we highlight the current challenges in the field and the strategies, which may be used for overcoming the impediments.
UR - http://www.scopus.com/inward/record.url?scp=85123648801&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123648801&partnerID=8YFLogxK
U2 - 10.2174/1871527320666210311122921
DO - 10.2174/1871527320666210311122921
M3 - Review article
C2 - 33719979
AN - SCOPUS:85123648801
VL - 21
SP - 62
EP - 76
JO - CNS and Neurological Disorders - Drug Targets
JF - CNS and Neurological Disorders - Drug Targets
SN - 1871-5273
IS - 1
ER -